KEYCEPT 500MG TABLET

Keycept 500 mg Tablet is an immunosuppressant with an active ingredient, Mycophenolate mofetil. It falls under the inosine monophosphate dehydrogenase (IMPDH) inhibitor class. It is prescribed to avoid rejection of organs in people who have had the organs of a donor (such as heart, kidney transplantation of the liver, for instance). It is usually prescribed as a part of a mixed treatment incorporating other immunosuppressive medications.
This medication is not recommended during pregnancy due to the possibility of miscarriage or congenital disabilities. It should not be used during pregnancy unless there are other alternatives and the advantages outweigh the risks. Women who are born are strongly advised to make use of effective contraception when taking this tablet to avoid pregnancies. Live vaccines shouldn’t be administered while a patient is taking Keycept 500 mg Tablet due to the reduced effectiveness and risk of contracting infection. People taking this medication are not allowed to donate blood during treatment and, at minimum, six weeks after having stopped treatment. This ensures that the drug is eliminated from the body before blood donation is made.
It is usually advised not to take this drug if you are allergic to the medication or other components. Inform your doctor about heart or liver problems before beginning treatment. Because this drug weakens the body’s immune system, it increases the risk of developing skin cancer. People should reduce their exposure to the sun and the ultraviolet (UV) ultraviolet (UV) light. Consult your physician immediately if you experience any bleeding on the skin, fever, unprovoked tiredness, dizziness, other symptoms, discoloration of the skin or eyes, vision impairment, diminished urine output, or seizures following this medication. Keycept 500 mg Tablet is an immunosuppressive drug. It can affect the infant’s developing immune system and should not be used during breastfeeding. In certain situations, alternatives to medications that have an enhanced safety profile while breastfeeding could be thought of as.